{"doi":"10.1016/j.jval.2022.09.2430","title":"SA36 Is Progression-Free Survival a Good Indicator of Overall Survival for Pazopanib in Patients With Synovial Sarcoma?","abstract":null,"journal":"Value in Health","year":2022,"id":45608,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":212853,"name":"S Lee","orcid":null,"position":1,"is_corresponding":false},{"id":212854,"name":"E Cho","orcid":null,"position":2,"is_corresponding":false},{"id":212852,"name":"J Han","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"21071399","pmcid":null,"openalex_id":"https://openalex.org/W4311341306","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.26248524,"influential_citations":0,"citation_trend":[],"oa_status":"closed","license":"http://www.elsevier.com/open-access/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S1098301522046356?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1098301522046356?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.jval.2022.09.2430","host_type":"journal"}],"fields_of_study":["Sarcoma Diagnosis and Treatment","Lymphoma Diagnosis and Treatment","Colorectal and Anal Carcinomas","Medicine"],"mesh_terms":[],"keywords":["Pazopanib","Medicine","Soft tissue sarcoma","Internal medicine","Oncology","Synovial sarcoma","Sarcoma","Confidence interval","Progression-free survival","Clinical endpoint","Surrogate endpoint","Proportional hazards model","Overall survival","Clinical trial","Pathology","Cancer"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"No poverty"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-03T22:53:34.534307Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}